Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physical absorption of blood is a physiological or mechanical process rather than a specific molecular target such as a protein, enzyme, or receptor. In a clinical context, it refers to the capacity of hemostatic materials—such as sponges, gauzes, or polymers—to take up blood at an injury site [1]. This physical uptake concentrates platelets and endogenous clotting factors into a localized matrix, providing a physical scaffold that facilitates fibrin formation and the natural coagulation cascade [2]. While this mechanism is essential for managing surgical hemorrhage and trauma, it is a property of biomaterials and medical devices rather than a drug-targetable signaling molecule. Consequently, it does not meet the standard criteria for a therapeutic molecular target [3].
Physical entrapment of blood cells and proteins within a matrix to promote clot formation and provide mechanical tamponade.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical absorption of blood.